{"filing":{"accession_number":"0001171843-26-006686","cik":"0001505065","ticker":"BRSYF","company_name":"Brainsway Ltd.","form":"6-K","filing_date":"2026-10-19","report_date":"2026-10-19","primary_document":"f6k_101926.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1505065/000117184326006686/f6k_101926.htm"},"events":[{"id":36028,"run_id":33216,"accession_number":"0001171843-26-006686","anchor_item_number":"EX-99.1","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"BrainsWay announced a strategic collaboration with Inland Psychiatric Medical Group involving a multisystem order of Deep TMS systems and exploration of joint scientific and clinical research projects. This is a material operational/commercial partnership that expands the company's market reach and clinical applications, but does not fit the specific categories of M\u0026A activity, debt issuance, or other defined event types. The collaboration represents a significant business development milestone for a medical device company seeking to accelerate adoption of its neurostimulation platform.","company_name":"Brainsway Ltd.","ticker":"BRSYF","filing_date":"2026-10-19","form":"6-K","submitted_at":null,"items":[{"id":40298,"accession_number":"0001171843-26-006686","item_number":"EX-99.1","item_title":"exh_991.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"BrainsWay announced a strategic collaboration with Inland Psychiatric Medical Group involving a multisystem order of Deep TMS systems and exploration of joint scientific and clinical research projects. This is a material operational/commercial partnership that expands the company's market reach and clinical applications, but does not fit the specific categories of M\u0026A activity, debt issuance, or other defined event types. The collaboration represents a significant business development milestone for a medical device company seeking to accelerate adoption of its neurostimulation platform.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-19T16:01:38.145245+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":40298,"accession_number":"0001171843-26-006686","item_number":"EX-99.1","item_title":"exh_991.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"BrainsWay announced a strategic collaboration with Inland Psychiatric Medical Group involving a multisystem order of Deep TMS systems and exploration of joint scientific and clinical research projects. This is a material operational/commercial partnership that expands the company's market reach and clinical applications, but does not fit the specific categories of M\u0026A activity, debt issuance, or other defined event types. The collaboration represents a significant business development milestone for a medical device company seeking to accelerate adoption of its neurostimulation platform.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-19T16:01:38.145245+00:00","company_name":"Brainsway Ltd.","ticker":"BRSYF","filing_date":"2026-10-19"}]}